Triglobal Bioscience

Ahmedabad, India Founded: 2013 • Age: 13 yrs
Developer of generic diabetes, cancer, and cardiovascular products

About Triglobal Bioscience

Triglobal Bioscience was a Healthcare company based in Ahmedabad (India) founded in 2013. Developer of generic diabetes, cancer, and cardiovascular products. It operates on a Traditional Pharmaceuticals model. Its Indian entity Vitaaglobal Bioscience Private Limited reported revenue of β‚Ή99.3 Lakh. The company is recorded as dissolved. Triglobal Bioscience offers products and services including Triglobal Bioscience Platform. Its focus areas include Traditional Pharmaceuticals, Generics, Companies and Diversified.

Company details

Triglobal Bioscience developer of generic diabetes, cancer, and cardiovascular products, focusing on providing healthcare solutions, traditional pharmaceuticals, traditional pharmaceuticals, and providing healthcare solutions. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.

Key Metrics
  • Annual Revenue
    ₹99.3 Lakh

    FY 2024 · +4% YoY

  • Net Loss
    -₹56.8 Lakh

    FY 2024 · -57% margin

  • EBITDA
    -₹5.4 Lakh

    FY 2024 · -5% margin

Products & Services of Triglobal Bioscience

Triglobal Bioscience offers a comprehensive portfolio of products and services, including Triglobal Bioscience Platform.

Triglobal Bioscience Platform
Healthcare

Developer of generic diabetes, cancer, and cardiovascular products

Board of directors of Vitaaglobal Bioscience Private Limited (Triglobal Bioscience)

Vitaaglobal Bioscience Private Limited is the primary company behind Triglobal Bioscience. The board of Vitaaglobal Bioscience Private Limited currently have 3 directors; the longest-serving is Girish Bhatt, appointed in 2013. 3 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Girish Bhatt
DIN 02207645
Director23 Jul 201313 yrs 3 moVitaaglobal Bioscience Private Limited
Jayendra Mehta
DIN 08210602
Director05 Jul 20251 yr 3 moVitaaglobal Bioscience Private Limited
Hemant Amrish Parikh
DIN 00027820
Additional Director03 Nov 202511 moVitaaglobal Bioscience Private Limited

Financials of Triglobal Bioscience

Figures of Vitaaglobal Bioscience Private Limited, the primary company behind Triglobal Bioscience, for FY 2024. Revenue was ₹99.3 Lakh (+4% year on year). Net loss was -₹56.8 Lakh (-57% margin). EBITDA was -₹5.4 Lakh (-5% margin). Revenue has grown at a compounded annual rate of -11% over three years and +28% over five years.

  • ₹99.3 LakhRevenue · FY 2024 · +4% YoY
  • -₹56.8 LakhNet loss · -57% margin
  • -₹5.4 LakhEBITDA · -5% margin
  • ₹50 LakhPaid-up capital
  • 12Employees (provident fund records)
  • -11%Revenue CAGR, 3 years
  • +28%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Vitaaglobal Bioscience Private Limited are on its company page.

Premium access

Detailed financial statements for Triglobal Bioscience

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Triglobal Bioscience

Triglobal Bioscience was founded in 2013.

Triglobal Bioscience is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.

The primary company behind Triglobal Bioscience, Vitaaglobal Bioscience Private Limited, reported revenue of β‚Ή99.3 Lakh for FY 2024, up 4% year on year.

Triglobal Bioscience developer of generic diabetes, cancer, and cardiovascular products, focusing on providing healthcare solutions, traditional pharmaceuticals, traditional pharmaceuticals, and providing healthcare solutions. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.

Triglobal Bioscience offers Triglobal Bioscience Platform.

Triglobal Bioscience operates through Vitaaglobal Bioscience Private Limited.

The legal entities of Triglobal Bioscience currently have 3 directors, including Hemant Amrish Parikh, Girish Bhatt, Jayendra Mehta.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available